Biosafety Gene Therapy: Navigating the Regulatory Maze

Time

Tue, Jun 16 9:00AM
T 03

Title

Biosafety Gene Therapy: Navigating the Regulatory Maze

Abstract Summary

ORAL PRESENTATION SCHEDULED: Tuesday in Session #1A at 9:49-9:54 am Location: Exhibit Hall Poster Area (Hall A Entrance)

2012 to 2014 survey of all Institutional Biosafety Committees through a Freedom of Information Act Request to the NIH Office of Biotechnology Activities to ascertain research involving genetically modified biological materials.

Poster Presenter

Chris Jenkins
PhD, MPH,
Principal Partner and Chief Gene Therapy Biosafety Officer,
Clinical Biosafety Services, LLC
United States